Friday, September 15, 2017 10:15 PM ET
Insider at OPKO Health (OPK) Makes Significant purchase of Stock Extends the Trend of Last Quarter
Substantial insider buying activity was revealed in OPKO Health shares in a form 4 document filed with the SEC today, showing — Dr Phillip Frost, 10% Owner, Director and Officer — purchased 260,000 shares in the company having a net market value of approximately $1,555,624. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the purchase of 841,300 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 1,101,300 shares and have averaged 550,650 shares per transaction over this time period.
In relation to the peer group over the last 90 days, insider buy/sell trading at OPKO Health is above the 112-company peer group average. Pharmaceuticals peer group saw 111 buy/sell trades during this period for an average of 1.0 transactions per company. The number of shares per buy/sell trade for OPKO Health insiders was also higher. Within the peer group there were 2,876,768 shares purchased and 5,549,994 shares sold with company insiders selling 24,083 shares on average.
Significant insider buying and selling activity has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in data used in composing and writing this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.